免疫化学分析装置の世界市場 - 市場規模（セグメント別）、シェア、規制、償還、稼働台数、予測（～2033年）

免疫化学分析装置はその多用途性から、糖尿病、感染症検査、がん診断、心臓マーカー検査など、さまざまな症状の診断やモニタリングに利用されています。免疫化学分析装置市場は、その幅広い適応症への関与により規模が大きく、また多くの疾患の有病率の上昇や高齢化によって牽引されています。検査室の自動化に対する需要の高まりと、定期的な診断や患者のモニタリングに向けた継続的な使用により、免疫化学分析装置は市場金額の増加が予測され、甲状腺疾患、ウィメンズヘルス、糖尿病、感染症、心臓マーカー、がんなどの幅広い疾患に関連するパラメータを測定する検査室診断検査の主要な方法であり続ける見込みです。

当レポートでは、世界の免疫化学分析装置市場について調査分析し、各セグメントの市場規模、市場動向、競合情勢、COVID-19の影響などの情報を提供しています。

市場モデルの主な内容は以下の通りです。

上市済みの免疫化学分析装置と進化する競合情勢

• 主な業界動向の考察
• 免疫化学分析装置市場のセグメント別の年間収益と市場見通し（2015年～2033年）
• ユニット数、平均販売価格、市場金額に関する市場レベルのデータ

世界、地域、国レベルの市場固有の考察

• 世界の動向を地域別に分類した定性的な市場固有の情報と国別の考察
• 免疫化学分析装置市場のSWOT分析
• 免疫化学分析装置市場の競合力学の考察と動向

医療制度の概要を含む真の全体像を把握することで、市場の理解を促進します。また、市場参入セグメントでは、償還政策や規制情勢についての情報を提供し、市場力学をより深く掘り下げることができます。

• 国別の医療制度の概要
• 国別の償還政策
• 国別の医療技術に関する規制情勢

対象企業

• Abbott Laboratories
• Danaher Corp
• Bio-Rad Laboratories Inc
• F. Hoffmann-La Roche Ltd
• DiaSorin SpA
• bioMerieux SA
• Siemens Healthineers AG
• Quidelortho Corp
• Werfen Life Group SAU
• Hologic Inc
• Quanterix Corp
• Meridian Bioscience
• Agilent Technologies Inc
• Eurofins Scientific SE
• Revvity Inc
• Tecan Group Ltd
• STRATEC SE
• BMG Labtech GmbH
• Revvity Inc
• その他

Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033 is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area.

The model discusses in detail the impact of COVID-19 on Immunochemistry Analyzers market for the year 2020 and beyond. Due to their versatility, immunochemistry analyzers are relied upon for diagnosis and monitoring of a range of different conditions including diabetes, infectious disease testing, cancer diagnostics, and cardiac market tests. The immunochemistry analyzer market is large due to its involvement in a broad range of indications and is also being driven by rises in the prevalence of numerous diseases, as well as aging populations. Due to increased demand for lab automation and their continued use for routine diagnostic and patient monitoring purposes, immunochemistry analyzers are expected to increase in market value and will continue to be a primary method for laboratory diagnostic testing, measuring parameters linked to a wide range of diseases such as thyroid disorders, women's health, diabetes, infectious diseases; cardiac markers; and cancer.

Immunochemistry Analyzers model includes Chemiluminescence (CLIA), Immunofluorescence, Enzyme Immuno Assays (EIAs) and Point-Of-Care (POC) Analyzers as sub-segments.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with installed base. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Immunochemistry Analyzers and evolving competitive landscape:

• Insightful review of the key industry trends.
• Annualized total Immunochemistry Analyzers market revenue by segment and market outlooks from 2015- 2033.
• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights:

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Immunochemistry Analyzers market.
• Competitive dynamics insights and trends provided for Immunochemistry Analyzers market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Abbott Laboratories, Danaher Corp, Bio-Rad Laboratories Inc, F. Hoffmann-La Roche Ltd, DiaSorin SpA, bioMerieux SA, Siemens Healthineers AG, Quidelortho Corp, Werfen Life Group SAU, Hologic Inc, Quanterix Corp, Meridian Bioscience , Agilent Technologies Inc, Eurofins Scientific SE, Revvity Inc, Tecan Group Ltd, STRATEC SE, BMG Labtech GmbH, Revvity Inc and others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for:

• CMO executives who must have deep understanding of the Immunochemistry Analyzers market place to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to:

• Understand the impact of COVID-19 on Immunochemistry Analyzers market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Immunochemistry Analyzers market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Immunochemistry Analyzers market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
• Track device sales in the global and country-specific Immunochemistry Analyzers market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.